|
1
|
Shehata MA and Karim NA: Influenza
vaccination in cancer patients undergoing systemic therapy. Clin
Med Insights Oncol. 8:57–64. 2014.PubMed/NCBI
|
|
2
|
Lo HW, Hsu SC and Hung MC: EGFR signaling
pathway in breast cancers: From traditional signal transduction to
direct nuclear translocalization. Breast Cancer Res Treat.
95:211–218. 2006. View Article : Google Scholar
|
|
3
|
Ribeiro FA, Noguti J, Oshima CT and
Ribeiro DA: Effective targeting of the epidermal growth factor
receptor (EGFR) for treating oral cancer: A promising approach.
Anticancer Res. 34:1547–1552. 2014.PubMed/NCBI
|
|
4
|
Zahonero C and Sánchez-Gómez P:
EGFR-dependent mechanisms in glioblastoma: Towards a better
therapeutic strategy. Cell Mol Life Sci. 71:3465–3488. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arfaoui A, Kriaa L, Znaidi N, Gritli S,
Bouacha H, Zermani R and Rammeh S: Over-expression of EGFR is
closely correlated to poor prognosis in Tunisian patients with
non-small cell lung adenocarcinoma. J Immunoassay Immunochem.
35:256–268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Su JC, Lin KL, Chien CM, Chuang PW, Chang
LS and Lin SR: Concomitant inactivation of the epidermal growth
factor receptor, phosphatidylinositol 3-kinase/Akt and Janus
tyrosine kinase 2/signal transducer and activator of transcription
3 signalling pathways in cardiotoxin III-treated A549 cells. Clin
Exp Pharmacol Physiol. 37:833–840. 2010.PubMed/NCBI
|
|
7
|
Subramaniam A, Shanmugam MK, Ong TH, Li F,
Perumal E, et al: Emodin inhibits growth and induces apoptosis in
an orthotopic hepatocellular carcinoma model by blocking activation
of STAT3. Br J Pharmacol. 170:807–821. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fang Z, Tang Y, Fang J, Zhou Z, Xing Z, et
al: Simvastatin inhibits renal cancer cell growth and metastasis
via AKT/mTOR, ERK and JAK2/STAT3 pathway. PLoS One. 8:e628232013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weerasinghe P, Garcia GE, Zhu Q, Yuan P,
Feng L, et al: Inhibition of Stat3 activation and tumor growth
suppression of non-small cell lung cancer by G-quartet
oligonucleotides. Int J Oncol. 31:129–136. 2007.PubMed/NCBI
|
|
10
|
Zhang X, Yue P, Page BD, Li T, Zhao W, et
al: Orally bioavailable small-molecule inhibitor of transcription
factor Stat3 regresses human breast and lung cancer xenografts.
Proc Natl Acad Sci USA. 109:9623–9628. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kortylewski M and Yu H: Stat3 as a
potential target for cancer immunotherapy. J Immunother.
30:131–139. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tai WT, Cheng AL, Shiau CW, Huang HP,
Huang JW, et al: Signal transducer and activator of transcription 3
is a major kinase-independent target of sorafenib in hepatocellular
carcinoma. J Hepatol. 55:1041–1048. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koppenol WH, Bounds PL and Dang CV: Otto
Warburg’s contributions to current concepts of cancer metabolism.
Nat Rev Cancer. 11:325–337. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hernández JF, Urueña CP, Cifuentes MC,
Sandoval TA, Pombo LM, Castañeda D, Asea A and Fiorentino S: A
Petiveria alliacea standardized fraction induces breast
adenocarcinoma cell death by modulating glycolytic metabolism. J
Ethnopharmacol. 153:641–649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen WL, Wang JH, Zhao AH, Xu X, Wang YH,
et al: A distinct glucose metabolism signature of acute myeloid
leukemia with prognostic value. Blood. 124:1645–1654. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Venmar KT, Kimmel DW, Cliffel DE and
Fingleton B: IL4 receptor α mediates enhanced glucose and glutamine
metabolism to support breast cancer growth. Biochim Biophys Acta.
1853:1219–1228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen J, Zhang S, Li Y, Tang Z and Kong W:
Hexokinase 2 overexpression promotes the proliferation and survival
of laryngeal squamous cell carcinoma. Tumour Biol. 35:3743–3753.
2014. View Article : Google Scholar
|
|
19
|
Wang TX, Liu YH and Shi XY: Oridonin
induces apoptosis of HepG2 cells via downregulating STAT3-HK II
pathway. Chinese Pharmacological Bulletin. 30:397–402. 2014.In
Chinese.
|
|
20
|
Li J, Liu T, Zhao L, Chen W, Hou H, et al:
Ginsenoside 20(S)-Rg3 inhibits the Warburg effect through STAT3
pathways in ovarian cancer cells. Int J Oncol. 2:775–781. 2015.
|
|
21
|
Li Z, Li X, Wu S, Xue M and Chen W: Long
non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase
2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci.
105:951–955. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moiseeva EP, Heukers R and Manson MM: EGFR
and Src are involved in indole-3-carbinol-induced death and cell
cycle arrest of human breast cancer cells. Carcinogenesis.
28:435–445. 2007. View Article : Google Scholar
|
|
23
|
Chen J, Wang W, Wang H, Liu X and Guo X:
Combination treatment of ligustrazine piperazine derivate DLJ14 and
adriamycin inhibits progression of resistant breast cancer through
inhibition of the EGFR/PI3K/Akt survival pathway and induction of
apoptosis. Drug Discov Ther. 8:33–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamaguchi H and Wang HG: The protein
kinase PKB/Akt regulates cell survival and apoptosis by inhibiting
Bax conformational change. Oncogene. 20:7779–7786. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Le Gall M, Chambard JC, Breittmayer JP,
Grall D, Pouysségur J and Van Obberghan Schilling E: The p42/p44
MAP kinase pathway prevents apoptosis induced by anchorage and
serum removal. Mol Biol Cell. 11:1103–1112. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grandis JR, Drenning SD, Chakraborty A,
Zhou MY, Zeng Q, et al: Requirement of Stat3 but not Stat1
activation for epidermal growth factor receptor-mediated cell
growth in vitro. J Clin Invest. 102:1385–1392. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tai WT, Cheng AL, Shiau CW, Liu CY, Ko CH,
et al: Dovitinib induces apoptosis and overcomes sorafenib
resistance in hepatocellular carcinoma through SHP-1-mediated
inhibition of STAT3. Mol Cancer Ther. 11:452–463. 2012. View Article : Google Scholar
|
|
28
|
Wicke L, Engels JW, Gambari R and Saab AM:
Synthesis and antiproliferative activity of quinolone nucleosides
against the human myelogenous leukemia k-562 cell line. Arch Pharm
(Weinheim). 346:757–765. 2013. View Article : Google Scholar
|
|
29
|
Shou KJ, Li J, Jin Y and Lv YW: Design,
synthesis, biological evaluation, and molecular docking studies of
quinolone derivatives as potential antitumor topoisomerase I
inhibitors. Chem Pharm Bull (Tokyo). 61:631–636. 2013. View Article : Google Scholar
|
|
30
|
Bargou RC, Wagener C, Bommert K, Mapara
MY, Daniel PT, et al: Overexpression of the death-promoting gene
bax-alpha which is downregulated in breast cancer restores
sensitivity to different apoptotic stimuli and reduces tumor growth
in SCID mice. J Clin Invest. 97:2651–2659. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bargou RC, Daniel PT, Mapara MY, Bommert
K, Wagener C, et al: Expression of the bcl-2 gene family in normal
and malignant breast tissue: Low bax-alpha expression in tumor
cells correlates with resistance towards apoptosis. Int J Cancer.
60:854–859. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Blando JM, Carbajal S, Abel E, Beltran L,
Conti C, et al: Cooperation between Stat3 and Akt signaling leads
to prostate tumor development in transgenic mice. Neoplasia.
13:254–265. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin J, Tang H, Jin X, Jia G and Hsieh JT:
p53 regulates Stat3 phosphorylation and DNA binding activity in
human prostate cancer cells expressing constitutively active Stat3.
Oncogene. 21:3082–3088. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vangala Jr, Dudem S, Jain N and Kalivendi
SV: Regulation of PSMB5 protein and β subunits of mammalian
proteasome by constitutively activated signal transducer and
activator of transcription 3 (STAT3): Potential role in
bortezomib-mediated anticancer therapy. J Biol Chem.
289:12612–12622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu K, Chang Q, Lu Y, Qiu P, Chen B, et al:
Gefitinib resistance resulted from STAT3-mediated Akt activation in
lung cancer cells. Oncotarget. 4:2430–2438. 2013.PubMed/NCBI
|
